Do you want to read an article? Please log in or register.
Screening for Pulmonary Hypertension in Interstitial Lung Disease: Preliminary Results from the PHINDER Study
Pulmonary Hypertension
Related content
RECOMMENDED
Interstitial Lung DiseasePulmonary Hypertension
Sotatercept for Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease: Efficacy and Safety Insights
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Dagher C, Akiki M, Swanson K, Carollo B, Fiscus G, Farber HW, Parikh R
doi: 10.3390/jcm14155177
COMMENTED
Interstitial Lung Disease
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease. Developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM
doi: 10.1183/13993003.02533-2024
Further Publications
Efficacy of Pulmonary Rehabilitation on Patient-Reported Outcomes in Interstitial Lung Disease: A Quasi-Experimental Study
Respir Med
Panwar M, Patnaik SK, Marwah V, Patrikar S, Pandey I, Samiullah M, Parankusam KC
doi: 10.1016/j.rmed.2025.108459
Interstitial Lung DiseaseFurther Publications
The importance of considering progression speed in systemic sclerosis-associated interstitial lung diseases: application of 2022 and 2024 clinical practice guidelines for progressive pulmonary fibrosis, a retrospective cohort study
Respir Res
Roeser A, Brillet PY, Tran Ba S, Caux F, Dhote R, Nunes H, Uzunhan Y
doi: 10.1186/s12931-025-03375-7
Further Publications
The safety and efficacy of secondary spontaneous pneumothorax surgery: Especially in interstitial lung disease and chronic obstructive pulmonary disease
Eur J Cardiothorac Surg
Adachi T, Omasa M, Takehara R, Nakanishi T, Motoyama H
doi: 10.1093/ejcts/ezaf410
Lung Cancer
Lung Cancer Screening Adherence in Centralized versus Decentralized Screening Programs A Meta-Analysis of U.S. Cohort Studies Among Individuals with Negative Baseline Results
Chest
Ezenwankwo E, Jones C, Nguyen DT, Eberth JM
doi: 10.1016/j.chest.2025.04.033
RECOMMENDED
AsthmaCOPDInterstitial Lung Disease
Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax
Whittaker H, Kramer Fiala Machado A, Hatam S, Cook S, Scully S, Evans HTT, Bolton T, Kallis C, Busby J, Heaney LG, Sheikh A, Quint JK, CVD-COVID-UK/COVID-IMPACT Consortium
doi: 10.1136/thorax-2024-222699
Interstitial Lung DiseaseLung Cancer
Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study
Thorax
Karayama M, Miyashita K, Inoue Y, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Suda T
doi: 10.1136/thorax-2025-223430
Lung Cancer
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)
Lung Cancer
Borghetti P, D'Angelillo R, Facheris G, Borghesi A, Bruni A, Ceruti P, Ferrari K, Filippi AR, Ramella S, Signorelli D, Pappagallo G, Ricardi U, Collaborators
doi: 10.1016/j.lungcan.2025.108807